Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|13|1896-1903

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.13, 2016-04, pp. : 1896-1903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atrial Fibrillation in Patients After Cardiovascular Surgery: Incidence, Risk Factors, Preventive and Therapeutic Strategies

By Burke S.W.   Solomon A.J.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 95-100

Adis International

Access to resources Recommend Favorite

Azimilide reduced the incidence of atrial fibrillation (AF) but had no effect on mortality in patients with left ventricular dysfunction after recent myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 551-572

Bentham Science Publishers

Access to resources Recommend Favorite

QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation: A Double-Blind, Randomized, Placebo-Controlled Trial

By Egstrup Kenneth  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 199-208

Adis International

Access to resources Recommend Favorite

In patients with atrial fibrillation, warfarin therapy commenced prior to detection of left atrial thrombus (LAT) reduces the incidence of stroke

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite